Does BLINATUMOMAB Cause Leukaemic infiltration extramedullary? 175 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 175 reports of Leukaemic infiltration extramedullary have been filed in association with BLINATUMOMAB (BLINCYTO). This represents 1.9% of all adverse event reports for BLINATUMOMAB.
175
Reports of Leukaemic infiltration extramedullary with BLINATUMOMAB
1.9%
of all BLINATUMOMAB reports
43
Deaths
16
Hospitalizations
How Dangerous Is Leukaemic infiltration extramedullary From BLINATUMOMAB?
Of the 175 reports, 43 (24.6%) resulted in death, 16 (9.1%) required hospitalization, and 11 (6.3%) were considered life-threatening.
Is Leukaemic infiltration extramedullary Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BLINATUMOMAB. However, 175 reports have been filed with the FAERS database.
What Other Side Effects Does BLINATUMOMAB Cause?
Pyrexia (1,064)
Acute lymphocytic leukaemia recurrent (977)
Cytokine release syndrome (952)
Off label use (590)
Death (588)
Neurotoxicity (530)
Drug ineffective (345)
Headache (335)
Neutropenia (265)
Febrile neutropenia (262)
What Other Drugs Cause Leukaemic infiltration extramedullary?
DEXAMETHASONE (16)
BORTEZOMIB (11)
GILTERITINIB (11)
CYCLOPHOSPHAMIDE (10)
LENALIDOMIDE (7)
AZACITIDINE (6)
CARFILZOMIB (6)
CYTARABINE (6)
METHOTREXATE (6)
VINCRISTINE (6)
Which BLINATUMOMAB Alternatives Have Lower Leukaemic infiltration extramedullary Risk?
BLINATUMOMAB vs BLONANSERIN
BLINATUMOMAB vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BLINATUMOMAB vs BOCEPREVIR
BLINATUMOMAB vs BOCOCIZUMAB
BLINATUMOMAB vs BONIVA